Analyst Ratings For Advanced Medical Solutions Group plc (LON:AMS)
Today, Numis Securities reiterated its Add rating on Advanced Medical Solutions Group plc (LON:AMS) with a price target of GBX 340.
There are 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings, no Buy Ratings on the stock.
The current consensus rating on Advanced Medical Solutions Group plc (LON:AMS) is Hold with a consensus target price of GBX 340 per share, a potential .
Some recent analyst ratings include
- 3/13/2019-Advanced Medical Solutions Group plc (LON:AMS) had its Add rating reiterated by Numis Securities with a GBX 340 price target
- 10/26/2017-Advanced Medical Solutions Group plc (LON:AMS) had its Hold rating reiterated by Panmure Gordon
- 4/4/2017-Advanced Medical Solutions Group plc (LON:AMS) had its Buy rating reiterated by Stifel Nicolaus with a GBX 270 price target
About Advanced Medical Solutions Group plc (LON:AMS)
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the advanced wound care, surgical, and wound closure markets worldwide. It operates through two segments, Branded and OEM. The company offers natural and synthetic polymers for use in advanced wound care dressings under the ActivHeal brand; medical adhesives for closing and sealing tissue under the LiquiBand brand name; and sutures and haemostats for the medical device market under the RESORBA brand. It also provides advanced wound care products and bulk materials to business-to-business partners and third party convertors. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Recent Trading Activity for Advanced Medical Solutions Group plc (LON:AMS)
Shares of Advanced Medical Solutions Group plc closed the previous trading session at 307,00 up +1,50 0,49 % with shares trading hands.
